Valneva SE (EPA:VLA)
France · Delayed Price · Currency is EUR 2.966
+0.040 (1.37%)
Aug 21, 2026, 5:35 PM CET
Valneva SE Employees
Valneva SE had 620 employees as of June 30, 2026.
Employees
620
Change
n/a
Growth
n/a
Revenue / Employee
€230,545
Profits / Employee
€254,274
Market Cap
562.49M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 620 | - | - |
| Dec 31, 2025 | 674 | -39 | -5.47% |
| Dec 31, 2024 | 713 | 37 | 5.47% |
| Dec 31, 2023 | 676 | -43 | -5.98% |
| Dec 31, 2022 | 719 | -43 | -5.64% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| DBV Technologies | 170 |
| Innate Pharma | 164 |
| Genfit | 161 |
| Transgene | 145 |
| MedinCell | 141 |
| Nanobiotix | 100 |
| Inventiva | 77 |
Valneva SE News
- 7 days ago - Pfizer, Valneva announce EMA validation for PF-07307405 MAA - TheFly
- 9 days ago - Valneva Stock (VLN) Soars Over 20% On Lyme Disease Vaccine Hopes - TipRanks
- 9 days ago - Pfizer And Valneva's Lyme Vaccine Clears EMA Review Gate - Nasdaq
- 9 days ago - Pfizer, Valneva's Lyme Disease Vaccine Application Validated By EMA - Nasdaq
- 9 days ago - Pfizer Inc.: Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency - Finanz Nachrichten
- 9 days ago - Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency - GlobeNewsWire
- 9 days ago - Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency - Wallstreet:Online
- 9 days ago - Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency - Business Wire